As cell and gene therapies offer newfound hope to patients, the journey to commercialization is fraught with obstacles. The need for greater efficiency, improved safety, and inventive approaches to pricing and access is paramount. Discover how leading CGTx innovators are tackling these challenges at Cell & Gene Day 2023.
Hosted by Endpoints News and co-sponsored by Precision ADVANCE, Center for Breakthrough Medicines, and Alliance for Regenerative Medicine, Cell & Gene Day 2023 brings you the most recent insights on cell and gene therapy research, development, manufacturing, and commercialization.
Through six panel discussions, you will gain knowledge from accomplished experts across the advanced therapy field, including representatives from the University of Pennsylvania, Blackstone, Alliance for Regenerative Medicine (ARM), Iovance Biotherapeutics, Spark Therapeutics, Kate Therapeutics, RegenXBio, and more. Cell & Gene Day 2023 is free to attend, but registration is necessary.
Rob Maiale is a seasoned healthcare writer, creative director, and content strategist with more than 15 years of experience covering a broad variety of therapeutic areas, indications, and technologies. His background spans pharma, diagnostics, medical devices, clinical and translational research, as well as patient education and outreach.
Precision for Medicine is part of the Precision Medicine Group, an integrated team of experts that extends Precision for Medicine’s therapeutic development capabilities beyond approval and into launch strategies, marketing communication, and payer insights. As one company, the Precision Medicine Group helps pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.
